McCray, Jr.; Paul B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McCray, Jr.; Paul B..The latest application filed is for "methods for producing and using in vivo pseudotyped retroviruses".

Company Profile

0.11.8

McCray, Jr.; Paul B. - Iowa City IA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of improving RNAi in well-differentiated airway epithelia Grant 9,987,299 - McCray, Jr. , et al. June 5, 2	2018-06-05
Methods For Producing And Using In Vivo Pseudotyped Retroviruses App 20170166924 - Davidson; Beverly L. ; et al.	2017-06-15
Halides In The Treatment Of Pathogenic Infection App 20160199407 - BANFI; Botond ; et al.	2016-07-14
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells Grant 9,272,016 - McCray, Jr. , et al. March 1, 2	2016-03-01
Methods Of Improving Rnai In Well-differentiated Airway Epithelia App 20150313924 - McCray, JR.; Paul B. ; et al.	2015-11-05
Methods To Enhance Rnai Oligonucleotide Delivery To Respiratory Epithelial Cells App 20130281372 - McCray, JR.; Paul B. ; et al.	2013-10-24
Methods and compositions related to PLUNC surfactant polypeptides Grant 7,951,781 - McCray, Jr. , et al. May 31, 2	2011-05-31
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) Grant 7,931,893 - McCray, Jr. , et al. April 26, 2	2011-04-26
Halides In The Treatment Of Pathogenic Infection App 20090246146 - BANFI; BOTOND ; et al.	2009-10-01
Methods For Producing And Using In Vivo Pseudotyped Retroviruses App 20090118212 - Davidson; Beverly L. ; et al.	2009-05-07
Methods and Compositions Related to PLUNC Surfactant Polypeptides App 20090110756 - McCray, JR.; Paul B. ; et al.	2009-04-30
Compositions and methods related to modified retroviral vectors for restricted, site specific integration Grant 7,470,777 - McCray, Jr. , et al. December 30, 2	2008-12-30
Methods For Producing And Using In Vivo Pseudotyped Retroviruses Using Envelope Glycoproteins From Lymphocytic Choriomeningitis Virus (lcmv) App 20080260693 - McCray, Jr.; Paul B. ; et al.	2008-10-23
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) Grant 7,439,066 - McCray, Jr. , et al. October 21, 2	2008-10-21
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) Grant 7,160,727 - McCray, Jr. , et al. January 9, 2	2007-01-09
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) Grant 7,135,339 - McCray, Jr. , et al. November 14, 2	2006-11-14
Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt Grant 7,071,293 - Tack , et al. July 4, 2	2006-07-04
Methods and compositions for increasing the infectivity of gene transfer vectors Grant 6,855,549 - McCray, Jr. , et al. February 15, 2	2005-02-15
Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide Grant 6,809,181 - McCray, Jr. , et al. October 26, 2	2004-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.